1408334-75-7

Usage

Uses

Used in Organic Synthesis:
2-(4-Iodo-1H-pyrazol-1-yl)ethanol is used as a reactant in organic synthesis for the preparation of various chemical compounds. Its unique structure and reactivity make it a valuable building block in the synthesis of complex organic molecules.
Used in Chemical Research:
In the field of chemical research, 2-(4-Iodo-1H-pyrazol-1-yl)ethanol serves as a versatile compound for studying reaction mechanisms, exploring new synthetic routes, and understanding the properties of related compounds.
Used in Pharmaceutical Industry:
2-(4-Iodo-1H-pyrazol-1-yl)ethanol is used as a starting material or intermediate in the development of pharmaceutical compounds. Its unique structure and potential biological activity make it a promising candidate for the synthesis of new drugs with therapeutic applications.
Used in Agrochemical Industry:
In the agrochemical industry, 2-(4-Iodo-1H-pyrazol-1-yl)ethanol may be utilized in the synthesis of agrochemicals, such as pesticides and herbicides. Its potential applications in this field could contribute to the development of more effective and environmentally friendly products.
Used in Drug Development:
2-(4-Iodo-1H-pyrazol-1-yl)ethanol is used as a potential candidate in the development of new drugs or therapies. Its biological activity and unique structure suggest that it may have therapeutic potential, warranting further research to explore its benefits in treating various diseases or conditions.

Upstream product

• 879487-88-4 4-iodo-1-[2-(tetrahydro-2H-pyran-2-yloxy)ethyl]-1H-pyrazole 
• 96-49-1 [1,3]-dioxolan-2-one 
• 3469-69-0 4-iodopyrazole 
• 540-51-2 2-bromoethanol 

Downstream Products

• 1578246-29-3 2-methoxy-4-(1-(2-(4-methylpiperazin-1-yl)ethyl)-1H-pyrazol-4-yl)aniline 
• 879488-19-4 2-(4-iodo-1H-pyrazol-1-yl)-N,N-dimethylethan-1-amine 
• 1578246-31-7 4-(1-(2-(dimethylamino)ethyl)-1H-pyrazol-4-yl)-2-methoxyaniline 
• 1578246-28-2 2-(4-iodo-1H-pyrazol-1-yl)ethyl 4-methylbenzenesulfonate 
• 1578246-34-0 1-(2-(tert-butyldiphenylsilyloxy)ethyl)-4-iodo-1H-pyrazole 
• 879488-16-1 4-[2-(4-iodo-1H-pyrazol-1-yl)ethyl]morpholine 

Relevant academic research and scientific papers

AZAINDOLE DERIVATIVE AND USE THEREOF AS FGFR AND C-MET INHIBITOR

A series of pyrazolopymidine derivatives, and use thereof in the preparation of a medicament for treating disease associated with FGFR and c-Met. The pyrazolopymidine derivative is a compound represented by formula (I), a tautomer, or a pharmaceutically acceptable salt thereof.

DERIVATIVES OF [1, 2, 4] TRIAZOLO [4, 3 - A] PYRIDINE AS P38 - MAP KINASE INHIBITORS

Mitogen activated protein kinase (MAPK) inhibitors disclosed herein are useful for the treatment of diseases of the respiratory tract, such as chronic eosinophilic pneumonia, asthma, COPD, adult respiratory distress syndrome (ARDS), exacerbation of airways hyper-reactivity consequent to other drug therapy, and airways disease that is associated with pulmonary hypertension.

INHIBITOR COMPOUNDS

The present invention relates to compounds of formula (I), wherein R, R, Ar, W, X and Z are all as defined herein. The compounds of the present invention are known to inhibit the spindle checkpoint function of Monospindle 1 (Mps1 - also known as TTK) kinases either directly or indirectly via interaction with the Mps1 kinase itself. In particular, the present invention relates to the use of these compounds as therapeutic agents for the treatment and/or prevention of proliferative diseases, such as cancer. The present invention also relates to processes for the preparation of these compounds, and to pharmaceutical compositions comprising them

KINASE INHIBITORS

Compounds of formula (I) described herein are p38 MAPK inhibitors and are useful as anti-inflammatory agents in the treatment of, inter alia, diseases of the respiratory tract.

DERIVATIVES OF [1, 2, 4] TRIAZOLO [4, 3 - A] PYRIDINE AS P38 - MAP KINASE INHIBITORS

This invention relates to compounds selected in the group consisting of compounds of formula (la) to (Id) and compositions, that are p38 MAPK inhibitors, useful as anti-inflammatory agents in the treatment of, inter alia, diseases of the respiratory tract.

KINASE INHIBITORS

This invention relates to compounds and compositions that are p38 MAPK inhibitors, useful as anti-inflammatory agents in the treatment of, inter alia, diseases of the respiratory tract.